-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on IN8bio, Lowers Price Target to $8

Benzinga·11/13/2024 13:54:29
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains IN8bio (NASDAQ:INAB) with a Buy and lowers the price target from $12.5 to $8.